The Burn Glove Trial - Hand Burn Dressing Pilot
Information source: Southern Illinois University
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Burns
Intervention: Aquacel Burn Silver (AG) glove (Other); antibiotic (Drug); Mepilex Transfer AG (Other)
Phase: Phase 1
Status: Not yet recruiting
Sponsored by: Southern Illinois University Official(s) and/or principal investigator(s): Nada N Berry, MD, Principal Investigator, Affiliation: Southern Illinois University
Overall contact: Thereasa E Abrams, PhD, LCSW, Phone: 217-545-8129, Email: tabrams@siumed.edu
Summary
Specific Aim 1: The primary purpose of this pilot trial is to determine if one of three
burn dressings promotes a more efficacious healing environment for partial-thickness hand
burns based on the studies' primary and secondary objectives.
Hypothesis 1: Days to complete wound healing of partial thickness hand burns will be
decreased with the use of Hydrofiber and silicone-based dressings compared to Bacitracin and
Xeroform, this institution's standard of care.
Clinical Details
Official title: The Burn Glove Trial-A Randomized Controlled Trial of Dressings for Partial Thickness Hand Burns
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Primary outcome: wound healing
Secondary outcome: painpatient/provider wound assessment
Detailed description:
There are various products on the market that are available for use on partial thickness
burns to the hand/s. Our current institutional standard of care is to use Xeroform Gauze
(Coviden, Mansfield, MA) and Bacitracin Ointment (Fougera, Melville, NY) to promote a moist
antibacterial healing environment with the ability to monitor the healing progress daily.
However, silver (AG) based dressings that employ nanocrystalline technology with hydrofiber
(Aquacel AG burn; ConvaTec, Princeton, NJ) or soft silicone foam (Mepilex AG ; Molnlycke
Health Care, Dunstable, United Kingdom) have been well accepted as alternative dressing
solutions. These dressings have longer interval times between changes, leading to a
reported increase in patient comfort, diminished skin shearing/stripping, and rapid
re-epithelialization.
Given the anatomic intricacies, partial thickness burns to the hand present a challenge in
dressing selection. Recently, ConvaTec unveiled the Aquacel AG Burn Glove for use on partial
thickness hand burns. In line with this idea, our institution has now begun to fashion a
novel burn glove out of Mepilex Transfer AG with good success. To date there are no known
studies that compare the healing rates of partial thickness hand burns when treated with
Xeroform/Bacitracin, Aquacel AG burn glove or Mepilex Transfer AG dressing. The goal of
this study is to assess the efficacy of three dressing types and determine which promotes
the most rapid, positive healing of burn wounds to the hand/s.
Eligibility
Minimum age: 8 Years.
Maximum age: 60 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients presenting at Memorial Medical Center, St. Johns Hospital and Southern
Illinois University (SIU) Health Care
- Patients with partial-thickness burn injuries to the dorsum and/or palm of the hand/s
that exceeds ½% total body surface area (TBSA) for at least one hand.
- < 10% TBSA 2nd and 3rd degree burn injuries
- In- and out-patients at Memorial Health Center, St. John's Hospital and SIU Health
Care.
- Initial clinical presentation < 5 days post burn injury
Exclusion Criteria:
- < ½ % TBSA involving the hand
- > 10%TBSA burn injuries
- > 60 years of age
- < 8 years of age
- Patients (or parents of minors) without cognitive capacity to comprehend informed
consent
- Full thickness/3rd degree burns to the dorsal and/or palmer hand/s
- Exposed vital structures (tendons, nerves, bone, vessels)
- Uncontrolled Type II Diabetes
- Type I Diabetes
- History of Chronic Obstructive Pulmonary Disease
- Have a known allergy to silver products
- Signs of infection on initial clinical presentation (presence of purulent drainage,
significant cellulitis, and/or fever)
- Smoke/inhalation injuries requiring ventilation
- Critically Ill patients requiring intensive care
Locations and Contacts
Thereasa E Abrams, PhD, LCSW, Phone: 217-545-8129, Email: tabrams@siumed.edu
Southern Illinois University School of Medicine, Springfield, Illinois 62794-9640, United States; Not yet recruiting Nada N Berry, MD, Principal Investigator Theresa E Abrams, PhD, LCSW, Sub-Investigator Shaun Mendenhall, MD, Sub-Investigator Amanda J Ross, MD, Sub-Investigator
Additional Information
Institute for Plastic Surgery, Office for Clinical Research
Related publications: Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD002106. doi: 10.1002/14651858.CD002106.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD002106. Robson MC, Smith DJ Jr, VanderZee AJ, Roberts L. Making the burned hand functional. Clin Plast Surg. 1992 Jul;19(3):663-71. Review. Kamolz LP, Kitzinger HB, Karle B, Frey M. The treatment of hand burns. Burns. 2009 May;35(3):327-37. doi: 10.1016/j.burns.2008.08.004. Epub 2008 Oct 25. Review. Walburn J, Vedhara K, Hankins M, Rixon L, Weinman J. Psychological stress and wound healing in humans: a systematic review and meta-analysis. J Psychosom Res. 2009 Sep;67(3):253-71. doi: 10.1016/j.jpsychores.2009.04.002. Epub 2009 Jul 2. Review. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns. 2007 Mar;33(2):139-48. Epub 2006 Nov 29. Review. Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol. 1996 May;26(3):255-60. Review. Bowler PG, Jones SA, Walker M, Parsons D. Microbicidal properties of a silver-containing hydrofiber dressing against a variety of burn wound pathogens. J Burn Care Rehabil. 2004 Mar-Apr;25(2):192-6.
Starting date: December 2014
Last updated: December 11, 2014
|